Jiangang Wang1, Yongyu Wang2, Jie Han3, Yan Li3, Changqing Xie4, Liqi Xie5, Jiahai Shi6, Jifeng Zhang7, Bo Yang8, Dong Chen9, Xu Meng3. 1. Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China. Electronic address: wangjiangang7545@126.com. 2. Department of Pathology, Shantou University Medical College, Shantou, People's Republic of China. Electronic address: yywangut@163.com. 3. Department of Cardiac Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China. 4. Department of Internal Medicine, Vidant Medical Center, Broody School of Medicine, East Carolina University, Greenville, North Carolina. 5. Shanghai Cancer Center and Institutes of Biomedical Sciences, Fudan University, Shanghai, People's Republic of China. 6. Department of Cardiothoracic Surgery, Affiliated Hospital of Nantong University, Nantong, People's Republic of China. 7. Center for Advanced Models for Translational Sciences and Therapeutics, University of Michigan Medical Center, Ann Arbor, Michigan. 8. University of Michigan Cardiovascular Center, University of Michigan, Ann Arbor, Michigan. 9. Department of Pathology, Beijing Anzhen Hospital, Capital Medical University, Beijing, People's Republic of China.
Abstract
BACKGROUND: Studies have reported that the integrated analysis of microRNA (miRNA)-messenger RNA (mRNA) expression is valuable in exploring gene regulation systemically. OBJECTIVES: The objectives of this study were to identify miRNAs and genes involved in atrial fibrillation and to explore the mechanisms underlying atrial fibrosis. METHODS: We used microarrays to compare the differences in both miRNA and mRNA expression profiles in the left atrial appendage of patients with nonvalvular paroxysmal atrial fibrillation and healthy controls. Furthermore, the quantitative real-time polymerase chain reaction was used to confirm the reliability of the microarray data, prediction of the adopted databases, and Ingenuity Pathway Analysis of miRNA-mRNA expression in order to identify the miRNA target genes, examine the functions and pathways in which the target genes are involved, and construct an miRNA-target gene regulatory network. We further investigated the roles of miRNA-146b-5p in the mechanisms of atrial fibrosis. RESULTS: We identified 10 differentially expressed miRNAs and 624 differentially expressed mRNAs, among which only 1 miRNA-target gene pair miR-146b-5p and tissue inhibitor of metalloproteinase 4 (TIMP-4) were constructed. The validated results revealed that miR-146b-5p, matrix metallopeptidase 9, and collagen content were upregulated whereas TIMP-4 was downregulated in patients with atrial fibrillation. After the transfection of miR-146b-5p into cardiac fibroblasts, TIMP-4 expression was markedly reduced and collagen content was increased. Moreover, luciferase results confirmed that TIMP-4 was a target of miR-146b-5p. CONCLUSION: The identified miRNA and mRNA may represent a potentially novel molecular regulatory network, which may provide a better understanding of the molecular basis of remodeling in atrial fibrillation. miR-146b-5p probably acts as an intracellular mediator in the maladaptive remodeling in atrial fibrosis in atrial fibrillation.
BACKGROUND: Studies have reported that the integrated analysis of microRNA (miRNA)-messenger RNA (mRNA) expression is valuable in exploring gene regulation systemically. OBJECTIVES: The objectives of this study were to identify miRNAs and genes involved in atrial fibrillation and to explore the mechanisms underlying atrial fibrosis. METHODS: We used microarrays to compare the differences in both miRNA and mRNA expression profiles in the left atrial appendage of patients with nonvalvular paroxysmal atrial fibrillation and healthy controls. Furthermore, the quantitative real-time polymerase chain reaction was used to confirm the reliability of the microarray data, prediction of the adopted databases, and Ingenuity Pathway Analysis of miRNA-mRNA expression in order to identify the miRNA target genes, examine the functions and pathways in which the target genes are involved, and construct an miRNA-target gene regulatory network. We further investigated the roles of miRNA-146b-5p in the mechanisms of atrial fibrosis. RESULTS: We identified 10 differentially expressed miRNAs and 624 differentially expressed mRNAs, among which only 1 miRNA-target gene pair miR-146b-5p and tissue inhibitor of metalloproteinase 4 (TIMP-4) were constructed. The validated results revealed that miR-146b-5p, matrix metallopeptidase 9, and collagen content were upregulated whereas TIMP-4 was downregulated in patients with atrial fibrillation. After the transfection of miR-146b-5p into cardiac fibroblasts, TIMP-4 expression was markedly reduced and collagen content was increased. Moreover, luciferase results confirmed that TIMP-4 was a target of miR-146b-5p. CONCLUSION: The identified miRNA and mRNA may represent a potentially novel molecular regulatory network, which may provide a better understanding of the molecular basis of remodeling in atrial fibrillation. miR-146b-5p probably acts as an intracellular mediator in the maladaptive remodeling in atrial fibrosis in atrial fibrillation.
Authors: Jonathan Chrispin; Esra Gucuk Ipek; Mohammadali Habibi; Eunice Yang; David Spragg; Joseph E Marine; Hiroshi Ashikaga; John Rickard; Ronald D Berger; Stefan L Zimmerman; Hugh Calkins; Saman Nazarian Journal: Europace Date: 2017-03-01 Impact factor: 5.214
Authors: Julie H Rennison; Ling Li; Cheryl R Lin; Beth S Lovano; Laurie Castel; Sojin Youn Wass; Catherine C Cantlay; Meghan McHale; A Marc Gillinov; Reena Mehra; Belinda B Willard; Jonathan D Smith; Mina K Chung; John Barnard; David R Van Wagoner Journal: Pflugers Arch Date: 2021-01-16 Impact factor: 3.657
Authors: Nicoline W E van den Berg; Makiri Kawasaki; Wouter R Berger; Jolien Neefs; Eva Meulendijks; Anke J Tijsen; Joris R de Groot Journal: Cardiovasc Drugs Ther Date: 2017-06 Impact factor: 3.727
Authors: Mario Torrado; Diego Franco; Estefanía Lozano-Velasco; Francisco Hernández-Torres; Ramón Calviño; Guillermo Aldama; Alberto Centeno; Alfonso Castro-Beiras; Alexander Mikhailov Journal: Biomed Res Int Date: 2015-06-28 Impact factor: 3.411